Review article: Emerging techniques for screening and surveillance in Barrett's oesophagus

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 5, 2004, Pages 63-70

  Sharma, P ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUGOL; METHYLENE BLUE;

ADENOCARCINOMA; BALLOON CYTOLOGY; BARRETT ESOPHAGUS; BRUSH CYTOLOGY; CANCER SCREENING; CHROMOENDOSCOPY; CONFERENCE PAPER; CYTOLOGY; DIAGNOSTIC ACCURACY; DYSPLASIA; EARLY DIAGNOSIS; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LIGHT SCATTERING; MAJOR CLINICAL STUDY; NARROW BAND IMAGING ENDOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SCREENING TEST; SPECTROSCOPY;

BARRETT ESOPHAGUS; BIOPSY; ESOPHAGOSCOPY; HUMANS; MASS SCREENING; SPECTRUM ANALYSIS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 7044238414     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus: the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998; 93: 1033-6.
2. Eloubeidi M, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1999; 94: 937-43.
3. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
4. Cameron A, Carpenter H. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92: 586-91.
5. Falk G, Rice T, Goldblum J, Richter JE. Jumbo biopsy protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999; 49: 170-6.
6. Reid BJ, Prevo LJ, Galipeau PC, et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 2001; 96: 2839-48.
7. Falk GW, Chittajallu R, Goldblum JR, et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 1997; 112: 2138-42.
8. Fennerty MB. Tissue staining. Gastrointest Endosc Clin N Am 1994; 4: 297-311.
9. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-8.
10. Connor M, Sharma P. Chromoendoscopy and magnification endoscopy in Barrett's esophagus. Gastrointest Endosc Clin N Am 2003; 13: 269-77.
11. Stevens PD, Lightdale CJ, Green PH, Siegel LM, Garcia-Carrasquillo RJ, Rotterdam H. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994; 40: 747-9.
12. Connor M, Sharma P, Chromoendoscopy and magnification endoscopy in Barrett's esophagus. Tech Gastrointest Endosc 2003; 5: 89-93.
13. Overholt BF, Panjehpour M, Halberg D. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003; 58: 183-8.
14. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996; 44: 1-7.
15. Sharma P, Topalovski M, Mayo M, Weston AP. Methylene blue chromoendoscopy for the detection of short-segment Barrett's esophagus. Gastrointest Endosc 2001; 54: 289-93.
16. Canto MI, Setrakian S, Willis J, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000; 51: 560-8.
17. Wo J, Ray M, Mayfield-Stokes S, et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study. Gastrointest Endosc 2001; 54: 294-301.
18. Dave U, Shousha AS, Westaby D. Methylene blue staining: is it really useful in Barrett's esophagus? Gastrointest Endosc 2001: 53: 333-5.
19. Breyer HP, Silva De Barros SG, Maguilnik I, Edelweiss MI. Does methylene blue detect intestinal metaplasia in Barrett's esophagus? Gastrointest Endosc 2003; 57: 505-9.
20. Olliver JR, Wild CP. Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003; 362: 373-4.
21. Endo T, Awakawa T, Takahashi H, et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 2002; 55: 641-7.
22. Sharma P, Weston AP, Topalovski M, et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003; 52: 24-7.
23. Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569-91.
24. Skacel M, Fahmy M, Gramlich TL, et al. Fluorescence in situ hybridization (FISH) of endoscopic brush cytology from Barrett's esophagus detects genetic changes in high-grade dysplasia and adenocarcinoma not seen in patients without dysplasia. Gastrointest Endosc 2003; 57: AB92.
25. Sharma P, McGregor D, Cherian R, Weston A. Use of narrow band imaging, a novel imaging technique, to detect intestinal metaplasia and high-grade dysplasia in patients with Barrett's esophagus. Gastrointest Endosc 2003; 57: AB77.
26. Panjehpour M, Overholt BF, Schmidhammer JL, Farris C, Buckley PF, Vo-Dinh T. Spectroscopic diagnosis of oesophageal cancer: new classification model, improved measurement system. Gastrointest Endosc 1995; 41: 577-81.
27. Mayinger B, Horner P, Jordan M, et al. Light-induced auto-fluorescence spectroscopy for the endoscopic detection of oesophageal cancer. Gastrointest Endosc 2001; 54: 195-201.
28. Panjehpour M, Overholt BF, Vo-Dinh T, Haggitt RC, Edwards DH, Buckley FP 3rd. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's oesophagus. Gastroenterology 1996; 111: 93-101.
29. Brand S, Wang TD, Schomacker KT, et al. Detection of high-grade dysplasia in Barrett's oesophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc 2002; 56: 479-87.
30. Ortner ME, Voderholzer W, Ebert B, et al. Fluorescence imaging and white light endoscopy system with fluorescence spectroscopy are complementary methods in detecting malignant lesions in Barrett's oesophagus. Gastroenterology 2002; 122: A31(Abstract).
31. Wallace M, Perelman L, Backman V, et al. Endoscopic detection of dysplasia in patients with Barrett's oesophagus using light-scattering spectroscopy. Gastroenterology 2000; 119: 677-82.
32. Georgakoudi I, Jacobson B, Van Dam J, et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's oesophagus. Gastroenterology 2001; 120: 1620-9.
33. Poneros JM, Brand S, Bouma BE, Tearney GJ, Compton CC, Nishioka NS. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology 2001; 120: 7-12.